IKE Kapuna (Elder Wisdom) Project

IKE Kapuna(长者智慧)项目

基本信息

项目摘要

RESEARCH PROJECT 2: ABSTRACT The prevalence of Alzheimer’s disease and related dementias (ADRD) is rising in Hawai`i, where it is projected that 10% of people aged 65+ will be diagnosed with ADRD by 2025. Nationwide, Native Hawaiians and Pacific Islanders (NHPIs) are more likely to have early-onset ADRD than Whites, Asians, and African Americans. NHPIs have a higher prevalence of hypertension, obesity, diabetes, and dyslipidemia than other US racial and ethnic groups, which increase the likelihood of ADRD. ADRD is often preceded by subjective cognitive impairment and mild cognitive impairment, which offers an opportunity for early intervention to prevent or delay ADRD onset. Interventions that promote physical activity, healthy diet, and social and cognitive activities can prevent or slow cognitive decline. Notably, dancing can preserve or improve cognitive functioning and neuroimaging parameters, while reducing vascular risk factors. However, very few studies have tailored a dance program for ADRD prevention for racial or ethnic minorities, and none have included NHPIs. We completed a randomized controlled trial of an intervention featuring Hula in 277 NHPIs with uncontrolled hypertension. Over 6 months, the intervention lowered systolic (-5.4 mmHg, p = 0.02) and diastolic (-4.4 mmHg, p = 0.01) blood pressure compared to the control condition. We therefore will partner with 5 community-based organizations in Hawai‘i to adapt our existing Hula intervention and test its effectiveness for improving vascular health and maintaining or improving cognitive function in NHPI elders at high risk of ADRD. The ‘IKE Kupuna (Elder Wisdom) Project will use qualitative methods to revise our existing 12-month Hula curriculum for hypertension with culturally informed dietary education, cognitive exercises, and social engagement strategies. We will then conduct a pragmatic group-randomized trial with 208 NHPIs aged 50-75 years with at least 1 of 4 modifiable vascular risk factors for ADRD (hypertension, hyperglycemia, obesity, or dyslipidemia) and either SCI or MCI using a wait-list control design. The primary outcomes will be vascular risk factors for ADRD and subjective cognitive complaints. Secondary outcomes will include measures of cognitive performance, physical function, and mental health. We will also collect biospecimens from all participants to evaluate the cross-sectional association between APOE genotype, vascular risk factors, and cognitive complaints and function. Our Specific Aims are to: 1) Adapt our existing Hula-based intervention to target vascular risk factors for dementia, improve cognitive symptoms or function, and optimize salience, implementation, and adherence in NHPIs with subjective cognitive impairment or mild cognitive impairment; 2) Conduct a group randomized trial to test the effect of ‘IKE Kupuna on vascular risk factors for ADRD and cognitive complaints and function over 12 months; and 3) Evaluate the cross-sectional association of vascular risk factors and APOE genotype with cognitive complaints and function. The NHPI elder population is increasing and their needs are escalating. This will be the first study to test a novel intervention to address ADRD in NHPIs and to assess the association APOE-ε4 genotype with cognitive function in this group.
研究课题2:摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Keawe'aimoku Kaholokula其他文献

Joseph Keawe'aimoku Kaholokula的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Keawe'aimoku Kaholokula', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10281543
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
IKE Kapuna (Elder Wisdom) Project
IKE Kapuna(长者智慧)项目
  • 批准号:
    10667550
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Strengthening Data Science Capacity for Biomedical Research Advancement at Hawaii
加强夏威夷生物医学研究进展的数据科学能力
  • 批准号:
    10872087
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
IKE Kapuna (Elder Wisdom) Project
IKE Kapuna(长者智慧)项目
  • 批准号:
    10172085
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
  • 批准号:
    10685388
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10685389
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
  • 批准号:
    10281542
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10474427
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
  • 批准号:
    10474426
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the Pacific
太平洋地区的癌症研究教育、进步、培训和赋权 (CREATE)
  • 批准号:
    10226218
  • 财政年份:
    2020
  • 资助金额:
    $ 51.94万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 51.94万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 51.94万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 51.94万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 51.94万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 51.94万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 51.94万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 51.94万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 51.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了